These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 39373754)

  • 1. [Current developments in urothelial carcinoma].
    Niegisch G; Kramer M
    Urologie; 2024 Oct; 63(10):975-976. PubMed ID: 39373754
    [No Abstract]   [Full Text] [Related]  

  • 2. A new standard of care for advanced-stage urothelial carcinoma.
    Sidaway P
    Nat Rev Clin Oncol; 2024 May; 21(5):336. PubMed ID: 38509334
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic strategies for upper tract urothelial carcinoma.
    Freifeld Y; Krabbe LM; Clinton TN; Woldu SL; Margulis V
    Expert Rev Anticancer Ther; 2018 Aug; 18(8):765-774. PubMed ID: 29848133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urothelial cancer of the urinary bladder: can lessons learned be applied to the upper urinary tract?
    Krabbe LM; Hutchinson RC; Margulis V
    Minerva Urol Nefrol; 2016 Aug; 68(4):396-408. PubMed ID: 26990295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial Comment on Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan.
    Ishihara H; Takagi T
    Int J Urol; 2024 May; 31(5):559-560. PubMed ID: 38366784
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial Comment to Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan.
    Kondo T
    Int J Urol; 2024 May; 31(5):560-561. PubMed ID: 38424666
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel therapeutic targets in advanced urothelial carcinoma.
    Rouanne M; Loriot Y; Lebret T; Soria JC
    Crit Rev Oncol Hematol; 2016 Feb; 98():106-15. PubMed ID: 26589398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter to the editor for the article "Molecular urothelial tumor cell subtypes remain stable during metastatic evolution".
    Song Y; Peng Y; Xu T
    World J Urol; 2023 Oct; 41(10):2869-2870. PubMed ID: 37516671
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial Comment on "Real-world treatment patterns and quality of life among patients with locally advanced or metastatic urothelial carcinoma living in Saudi Arabia, South Korea, Taiwan, and Turkey".
    Giudice GC; Sonpavde GP
    Int J Urol; 2024 Aug; 31(8):943-944. PubMed ID: 38825971
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative clinical trials with a novel approach: Utilizing the shiny method for investigational urothelial carcinoma therapies.
    Hara T; Suzuki K; Okada K; Chiba K; Teishima J; Miyake H
    Int J Urol; 2024 Oct; 31(10):1168-1170. PubMed ID: 38948961
    [No Abstract]   [Full Text] [Related]  

  • 11. The landscape of immunotherapy in metastatic urothelial carcinoma.
    Teo MY; Iyer G
    Curr Opin Urol; 2019 Nov; 29(6):643-648. PubMed ID: 31567441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapy in bladder cancer-quo vadis? Update on current trials and developments].
    Todenhöfer T; Boegemann M
    Urologe A; 2020 Jul; 59(7):810-816. PubMed ID: 32468092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urothelial carcinoma of the upper urinary tracts: current knowledge and future perspectives.
    Margulis V; Hutchinson R; Krabbe LM
    Minerva Urol Nefrol; 2016 Aug; 68(4):348-9. PubMed ID: 27404376
    [No Abstract]   [Full Text] [Related]  

  • 14. [Optimizing treatment of advanced urologic malignancies].
    Heidenreich A; Ohlmann CH; Ozgür E; Pfister D; Sahi D; Thüer D; Engelmann UH
    Urologe A; 2007 Sep; 46(9):1278-84. PubMed ID: 17628781
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of Oligometastatic and Locally Recurrent Urothelial Carcinoma.
    Liu MA; Li JW; Runcie K
    Curr Oncol Rep; 2024 May; 26(5):496-503. PubMed ID: 38602581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Trials Referral Resource. Clinical trials in bladder and urothelial cancers.
    Kaplan RS; Cheson BD; Nelson AP
    Oncology (Williston Park); 1997 Sep; 11(9):1348, 1351. PubMed ID: 9306423
    [No Abstract]   [Full Text] [Related]  

  • 17. [Organ preservation in cancer of the upper urinary tract].
    Vom Dorp F
    Urologe A; 2019 Jan; 58(1):22-24. PubMed ID: 30649581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental Pathogenic Variants in Renal Cell and Urothelial Carcinoma: Is It Time for Universal Screening?
    Jaime-Casas S; Yip W; Jeter JM
    JCO Precis Oncol; 2024 Jul; 8():e2400324. PubMed ID: 39088771
    [No Abstract]   [Full Text] [Related]  

  • 19. Salvage systemic therapy for advanced urothelial carcinoma: on the cusp of a sea change?
    Sonpavde G; Bellmunt J
    Oncologist; 2015 May; 20(5):461-3. PubMed ID: 25845991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions.
    Tripathi A; Plimack ER
    Curr Urol Rep; 2018 Nov; 19(12):109. PubMed ID: 30406502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.